Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FH0N3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,084
Award facts
- Contract value 100% obligated
- $18,083.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Gemtesa 75 mg tablets in quantities of 90 units. This is a firm fixed-price delivery order with a ceiling value of $18,083.93 and an ultimate completion date of August 20, 2025. The contract is not set-aside and represents a competitive award to the vendor, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999, which serves as a comprehensive global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a broad range of medications and medical commodities to support military and federal healthcare systems. The Gemtesa order fulfills federal medical procurement needs for the Defense Health Agency and other government healthcare customers. The company's extensive contract portfolio with DLA demonstrates its capability to supply specialty medications, brand-name and generic drugs, and specialized medical supplies across multiple therapeutic domains through open competition. The delivery order reflects the company's ongoing role as a critical vendor within the federal pharmaceutical supply chain supporting military healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FH0N3?
SPE2DB25FH0N3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FH0N3 worth?
The government has obligated $18,084 on SPE2DB25FH0N3.
Is contract SPE2DB25FH0N3 an order under another contract?
Yes. SPE2DB25FH0N3 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FH0N3 competed?
The extent of competition for SPE2DB25FH0N3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award